The Role of CD133 in Iron Metabolism and Endocytosis in Human Colon Cancer Cells
Author Information
Author(s): Bourseau-Guilmain Erika, Griveau Audrey, Benoit Jean-Pierre, Garcion Emmanuel
Primary Institution: Laboratoire d'Ingénierie de la Vectorisation Particulaire, Inserm, UMR-S 646, Université d'Angers, Angers, France
Hypothesis
CD133 is involved in endocytosis and regulates iron metabolism in human colon cancer Caco-2 cells.
Conclusion
CD133 inhibits transferrin endocytosis and is regulated by iron levels, suggesting a complex role in iron metabolism.
Supporting Evidence
- CD133 knockdown increased transferrin uptake in Caco-2 cells.
- Cholesterol extraction enhanced transferrin uptake in CD133high cells.
- AC133 antibody treatment reduced transferrin uptake.
- CD133 expression was downregulated by iron supplementation.
- CD133 was shown to inhibit transferrin receptor accessibility.
Takeaway
CD133 is a protein that helps cells take in iron, and when it's not there, cells can take in more iron. This is important for understanding how cancer cells work.
Methodology
The study used siRNA knockdown of CD133 in Caco-2 cells to assess its role in endocytosis and iron metabolism.
Limitations
The study primarily focused on a single cell line, which may limit the generalizability of the findings.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website